Matches in Wikidata for { <http://www.wikidata.org/entity/Q37669191> ?p ?o ?g. }
- Q37669191 description "article científic" @default.
- Q37669191 description "article scientifique" @default.
- Q37669191 description "articolo scientifico" @default.
- Q37669191 description "artigo científico" @default.
- Q37669191 description "artículu científicu espublizáu en 2017" @default.
- Q37669191 description "bilimsel makale" @default.
- Q37669191 description "scientific article published on 23 February 2017" @default.
- Q37669191 description "vedecký článok" @default.
- Q37669191 description "vetenskaplig artikel" @default.
- Q37669191 description "videnskabelig artikel" @default.
- Q37669191 description "vědecký článek" @default.
- Q37669191 description "wetenschappelijk artikel" @default.
- Q37669191 description "wissenschaftlicher Artikel" @default.
- Q37669191 description "наукова стаття, опублікована в лютому 2017" @default.
- Q37669191 description "научни чланак" @default.
- Q37669191 description "مقالة علمية نشرت في 23 فبراير 2017" @default.
- Q37669191 name "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 name "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 name "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations." @default.
- Q37669191 type Item @default.
- Q37669191 label "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 label "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 label "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations." @default.
- Q37669191 prefLabel "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 prefLabel "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 prefLabel "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations." @default.
- Q37669191 P1433 Q37669191-998AAE23-FC48-458A-A563-940AED69E5BF @default.
- Q37669191 P1476 Q37669191-FB624B2D-C113-4A80-8819-9F399854EF1F @default.
- Q37669191 P2093 Q37669191-1FE22CEE-2037-4A1A-970F-CC6E2A497352 @default.
- Q37669191 P2093 Q37669191-23BA6C71-E546-40F6-B906-58B76033D931 @default.
- Q37669191 P2093 Q37669191-361AFA35-EC10-4F73-9729-B817E8A73060 @default.
- Q37669191 P2093 Q37669191-4C6F25D7-3008-40CA-B3EC-D1CB7D5A3240 @default.
- Q37669191 P2093 Q37669191-929BB1B3-6416-4562-8623-B7E32D8C554E @default.
- Q37669191 P275 Q37669191-618da73b-9aca-47fb-a8e3-40838712079f @default.
- Q37669191 P2860 Q37669191-001963D4-3D20-424A-8E34-7C823B225A0F @default.
- Q37669191 P2860 Q37669191-01D5F083-A5E0-4BDD-901D-78D0F325C9F1 @default.
- Q37669191 P2860 Q37669191-051BE44F-CAD6-4519-9BC1-33C1A803CEDE @default.
- Q37669191 P2860 Q37669191-08A83337-930A-4D29-B02B-1A99730D3615 @default.
- Q37669191 P2860 Q37669191-09054DDB-4490-46CA-8A6C-BD2193FE7FFE @default.
- Q37669191 P2860 Q37669191-0AAF11BC-1D10-4BFE-961D-1BE6847646F6 @default.
- Q37669191 P2860 Q37669191-0B36D3C2-6486-4C8E-9DA2-7487F3ABE85E @default.
- Q37669191 P2860 Q37669191-107E154B-D6EF-4BAB-B5C6-FB0F170E3E7B @default.
- Q37669191 P2860 Q37669191-1085F83E-31E0-42F4-8CDB-F450606A17C9 @default.
- Q37669191 P2860 Q37669191-2E939AEB-4396-466B-BE32-2E37B6737CF2 @default.
- Q37669191 P2860 Q37669191-345C0933-1D7E-4E20-BCFB-B64A8879478A @default.
- Q37669191 P2860 Q37669191-4B85DDA1-F778-44EC-8073-E4651802D68E @default.
- Q37669191 P2860 Q37669191-4D55858D-3BEB-4F3D-AAFE-5D90CD8804ED @default.
- Q37669191 P2860 Q37669191-5E902BC3-19E2-4706-A989-3F8F78EB4363 @default.
- Q37669191 P2860 Q37669191-5EB622BE-9D38-4843-9F23-64C89AE22823 @default.
- Q37669191 P2860 Q37669191-73A80AFD-992F-4375-8FCD-89C736F73883 @default.
- Q37669191 P2860 Q37669191-8A6F49A7-D994-482B-9244-E02CAF555A6A @default.
- Q37669191 P2860 Q37669191-A383F777-16A7-4BE8-A2FF-223C09139CF3 @default.
- Q37669191 P2860 Q37669191-AAE06281-8B01-49B6-A8CD-AF0722A82FE4 @default.
- Q37669191 P2860 Q37669191-B1D225E3-F376-44B8-964C-1D42E02C2027 @default.
- Q37669191 P2860 Q37669191-B2385937-01A7-4549-BD0A-DCC257306624 @default.
- Q37669191 P2860 Q37669191-BE77938C-D559-436B-9714-B66AAF4807B3 @default.
- Q37669191 P2860 Q37669191-CC7CEC15-C297-4579-BF11-2B31EA3D98D8 @default.
- Q37669191 P2860 Q37669191-D2F1082A-61AF-45AF-88F2-0CE43EDD2F6A @default.
- Q37669191 P2860 Q37669191-FB77A97B-381A-4940-945C-40B304CE7043 @default.
- Q37669191 P304 Q37669191-56213936-7ABB-4B34-B69A-6A519797A0C4 @default.
- Q37669191 P31 Q37669191-A0F9A75E-6027-4FB3-B699-184640F37C39 @default.
- Q37669191 P356 Q37669191-5A461326-18FD-448C-98F3-B95F4DD0CA5D @default.
- Q37669191 P407 Q37669191-73AB66DD-B1DC-4641-9A3E-3049F169689B @default.
- Q37669191 P478 Q37669191-36F47E74-B2AE-42E6-A849-DDE001ACB135 @default.
- Q37669191 P577 Q37669191-1D64F3FA-3306-40BA-ACA4-B2FB10DBA3A7 @default.
- Q37669191 P6216 Q37669191-7fda70b4-3f27-4ffc-b8ad-eb146ec559fe @default.
- Q37669191 P698 Q37669191-6DBE9BE4-6013-4C85-A0A7-43F9DC78AD5E @default.
- Q37669191 P921 Q37669191-2121DEB7-E686-4917-A762-DACD2B4EFD11 @default.
- Q37669191 P921 Q37669191-C2C63CD0-4CE0-4A26-8BA2-86AD2E87B353 @default.
- Q37669191 P921 Q37669191-CF140D30-D87F-45DC-8104-AA56B13D223B @default.
- Q37669191 P932 Q37669191-AB18D848-E1DE-4666-93CA-D9CD816F5292 @default.
- Q37669191 P356 CPAA.S119875 @default.
- Q37669191 P698 28260952 @default.
- Q37669191 P1433 Q5133789 @default.
- Q37669191 P1476 "Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations" @default.
- Q37669191 P2093 "Ahmed S Zidan" @default.
- Q37669191 P2093 "Crystal B Spinks" @default.
- Q37669191 P2093 "Mansoor A Khan" @default.
- Q37669191 P2093 "Muhammad J Habib" @default.
- Q37669191 P2093 "Patrick J Faustino" @default.
- Q37669191 P275 Q18810331 @default.
- Q37669191 P2860 Q25257032 @default.
- Q37669191 P2860 Q26774223 @default.
- Q37669191 P2860 Q33426123 @default.
- Q37669191 P2860 Q33983070 @default.
- Q37669191 P2860 Q34981264 @default.
- Q37669191 P2860 Q37244357 @default.
- Q37669191 P2860 Q37304746 @default.
- Q37669191 P2860 Q38256497 @default.
- Q37669191 P2860 Q38456541 @default.
- Q37669191 P2860 Q39770671 @default.
- Q37669191 P2860 Q40468685 @default.
- Q37669191 P2860 Q41044551 @default.
- Q37669191 P2860 Q43638506 @default.
- Q37669191 P2860 Q44473040 @default.
- Q37669191 P2860 Q44541762 @default.
- Q37669191 P2860 Q44623886 @default.
- Q37669191 P2860 Q46261840 @default.
- Q37669191 P2860 Q46440529 @default.
- Q37669191 P2860 Q46515939 @default.